KMT2C and neoplasm: MLL3 is a mono-methyltransferase that targets lysine 4 (Lys4) from histone 3 (H3K4), an epigenetic mark that has been related to enhancer elements involved in the activation of tumor suppressor genes, thus its inactivation affects the protective mechanism against tumor development [9,10].